Refine by
Vaccine Efficacy Equipment & Supplies
16 equipment items found
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
KIN1148, a small-molecule IRF3 agonist, is a novel influenza vaccine adjuvant found to enhance flu vaccine ...
Manufactured by:Qingdao CareBios Biological Technology Co.,Ltd. based inQingdao, CHINA
A Vaccine Portable Ice Box is specifically designed to ensure the safe transportation and storage of vaccines at their required temperatures. These ice boxes are integral in maintaining the cold chain, crucial for vaccine efficacy. Engineered with advanced insulation materials, they provide a reliable thermal barrier to keep ...
Manufactured by:Optibio Co., Ltd. based inCheongju-si, SOUTH KOREA
Standard IgG/IgM antibody tests – which are universally available – do not detect for nAbs and can only provide an indirect indication for immunity. A SARS-CoV-2 nAb test can be used to monitor immunization against COVID-19, evaluate vaccine efficacy across vaccinated patients, and assess recovering ...
Manufactured by:OncoVITA based inParis, FRANCE
Measles live attenuated virus is one of the safest and most efficacious human vaccines that saves 2-3 million babies’ lives each year. The virus was attenuated in the 60s by serial passages on chicken cells giving rise to several attenuated strains among which the Schwarz strain is the most attenuated and widely used in human preventive ...
Manufactured by:Immunadd, Inc. based inTaipei City, TAIWAN
IA-05 is a truncated QS-21 analogue with improved tolerability, stability, and long-term immune responses in combination of various antigens. IA05 is expected to lead novel utilities in development of immunotherapies and therapeutic ...
by:Evaxion Biotech A/S based inHørsholm, DENMARK
RAVEN is our third proprietary AI platform that brings our unique, machine learning approach to vaccine design and development for viral diseases. RAVEN combines the essential AI tools from our PIONEER platform with structural bioinformatic tools from EDEN to arrive at a novel potent T- and B-cell vaccine design for emerging and mutating viral ...
Manufactured by:Genspeed Biotech GmbH based inRainbach, AUSTRIA
The COVID19 antibody test provides laboratory quality results on site within 20 minutes from just one drop of blood from the fingertip. As the test detects antibodies against 3 different SARS-CoV 2-Antigens, it is both highly sensitive and specific. This is impressively demonstrated in a publication in the Journal of Clinical Virology in which the GENSPEED COVID-19 IgG xPOC ...
Manufactured by:Polar Thermal Packaging Ltd based inWarminster, UNITED KINGDOM
The Vaccine – BluKoat Insulated Transport Bag is a cutting-edge solution designed for the secure and efficient transportation of vaccines. This product, designed by Polar Thermal Packaging, offers a sophisticated insulation system using patented Polar Thermal material with a thickness of 45mm to provide effective thermal protection. It ensures the ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines has developed a VesiculoVax™-vectored vaccine to protect against Lassa hemorrhagic ...
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
Herpes simplex virus-2 (HSV-2) is the leading cause of genital herpes, a sexually transmitted disease affecting over 500 million people worldwide. BlueWillow’s intranasal nanoemulsion (NE) vaccine is uniquely suited to offer protection against this painful and distressing affliction, through its ability to elicit both a systemic and mucosal immune ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
ResVax is our aluminum-adjuvanted RSV F vaccine for infants via maternal immunization. RSV is the most common cause of lower respiratory tract infections (LRTI) and the leading viral cause of severe lower respiratory tract disease in infants and young children worldwide. In the United States, RSV is the leading cause of hospitalization of infants and, globally, is second only to malaria as a ...
Manufactured by:CSL Seqirus UK Limited based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local public health needs. Our broad range influenza vaccines meets the needs of different populations around the world. Our marketed product range varies from ...
Manufactured by:Veravas, Inc. based inAustin, TEXAS (USA)
Multiplex detect antibodies in serum, plasma or saliva. The VeraPrep Antibody Detection Kit provides scientists with a state-of-the-art research tool to easily and quickly develop new tests to multiplex detect and measure immunoglobulins against new and emerging pathogens as well as autoantibodies against cardiac, neurologic, and cancer biomarkers. The ability to preanalytically remove sample ...
by:MSD Animal Health based inMilton Keynes, UNITED KINGDOM
An opaque fluid vaccine containing formalin killed cells expressing iron regulated antigens from the epidemiologically most important serotypes of Pasteurella haemolytica and Pasteurella trehalosi in buffered physiological saline and adsorbed onto aluminium hydroxide. Thiomersal is included as a preservative. For the active immunisation of sheep as an aid in the control of pasteurellosis caused ...
Manufactured by:Nirmidas Biotech, Inc. based inPalo Alto, CALIFORNIA (USA)
The test can be used for a variety of samples including serum, plasma, whole blood, dry blood spot, and saliva in a lab facility. It can be used to assess IgG and IgM levels in a sample with 100% sensitivity and 99.87% specificity without interferences from other diseases. Avidity pGOLD™ assay can tell if a COVID-19 infection is recent or remote greater than 6 months ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous vaccine models used inadequate ...